1,4-dihydropyridine has been researched along with Proteinuria in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gómez-Pliego, R; Gómez-Zamudio, J; Ibarra-Barajas, M; Velasco-Bejarano, B; Villalobos-Molina, R | 1 |
Bakris, GL; Greene, T; Hebert, L; Lea, J; Lipkowitz, M; Massry, S; Middleton, J; Miller, E; Rostand, SG; Smith, W | 1 |
García-Donaire, JA; Ruilope, LM; Segura, J | 1 |
Ferentinou, E; Kaperonis, N; Karakasis, F; Kourvelou, C; Ntatsis, G; Papagalanis, N; Ziakka, S | 1 |
1 review(s) available for 1,4-dihydropyridine and Proteinuria
Article | Year |
---|---|
Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy?
Topics: Albuminuria; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Calcium; Calcium Channel Blockers; Clinical Trials as Topic; Dihydropyridines; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Proteinuria | 2007 |
1 trial(s) available for 1,4-dihydropyridine and Proteinuria
Article | Year |
---|---|
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Black or African American; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Prognosis; Proteinuria; Ramipril; Risk Factors; Treatment Outcome; United States | 2005 |
2 other study(ies) available for 1,4-dihydropyridine and Proteinuria
Article | Year |
---|---|
Effect of bis-1,4-dihydropyridine in the kidney of diabetic rats.
Topics: Albuminuria; Animals; Body Weight; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dihydropyridines; In Vitro Techniques; Kidney; Male; Organ Size; Perfusion; Proteinuria; Rats; Rats, Wistar; Streptozocin; Vasodilation | 2013 |
Calcium channels blockers and progression of kidney disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Progression; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria | 2007 |